Primary chemotherapy for early and advanced breast cancer.
about
Optimal Management of Primary Breast Cancer.A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22.Initial Fludeoxyglucose (18F) Positron Emission Tomography-Computed Tomography (FDG-PET/CT) Imaging of Breast Cancer - Correlations with the Primary Tumour and Locoregional Metastases.Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome.
P2860
Primary chemotherapy for early and advanced breast cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Primary chemotherapy for early and advanced breast cancer.
@en
type
label
Primary chemotherapy for early and advanced breast cancer.
@en
prefLabel
Primary chemotherapy for early and advanced breast cancer.
@en
P2093
P1433
P1476
Primary chemotherapy for early and advanced breast cancer.
@en
P2093
Hortobagyi GN
Singletary SE
P304
P356
10.1016/0304-3835(94)03684-B
P407
P577
1995-03-01T00:00:00Z